Drugs Made In America Acquisition Corp. (DMAA)

Market Cap	341.04M
Revenue (ttm)	n/a
Net Income (ttm)	-479,734
Shares Out	33.52M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,282
Open	10.16
Previous Close	10.16
Day's Range	10.16 - 10.18
52-Week Range	9.95 - 10.27
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DMAA

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Jan 28, 2025
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: DMAA
• Website: https://dmaacorp.com

Financial Performance

Financial numbers in USD